Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 101 - 125 of 3913 in total
Main Class Sub Class LM ID Name ▲ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG00
  • Bleb
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1381
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG01
  • Bleb(d18:1/16:0)
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260660 1680.918588 C78H140N2O36
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG02
  • Bleb(d18:1/18:0)
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260661 1708.949888 C80H144N2O36
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG03
  • Bleb(d18:1/20:0)
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260662 1736.981188 C82H148N2O36
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG04
  • Bleb(d18:1/22:0)
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260663 1765.012488 C84H152N2O36
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG05
  • Bleb(d18:1/24:0)
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260664 1793.043788 C86H156N2O36
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG07
  • Bleb(d18:1/24:1(15Z))
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260666 1791.028138 C86H154N2O36
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG06
  • Bleb(d18:1/26:0)
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260665 1821.075088 C88H160N2O36
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG08
  • Bleb(d18:1/26:1(17Z))
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260667 1819.059438 C88H158N2O36
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT00
  • Branched Forssman
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1339
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT01
  • Branched Forssman(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260316 1794.961516 C82H146N4O38
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT02
  • Branched Forssman(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260317 1822.992816 C84H150N4O38
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT03
  • Branched Forssman(d18:1/20:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260318 1851.024116 C86H154N4O38
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT04
  • Branched Forssman(d18:1/22:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260319 1879.055416 C88H158N4O38
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT05
  • Branched Forssman(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260320 1907.086716 C90H162N4O38
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT07
  • Branched Forssman(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260322 1905.071066 C90H160N4O38
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT06
  • Branched Forssman(d18:1/26:0)
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260321 1935.118016 C92H166N4O38
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AT08
  • Branched Forssman(d18:1/26:1(17Z))
  • GalNAcalpha1-3GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260323 1933.102366 C92H164N4O38
Sphingoid bases Lysosphingomyelins and lysoglycosphingolipids LMSP01060003
  • C17 sphingosine-1-phosphocholine
  • heptadecasphing-4-enine-1-phosphocholine
44260120 184852 450.322261 C22H47N2O5P
Neutral glycosphingolipids GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AC00
  • CHS
  • GalNAcb1-4(GlcNAca1-2Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer
Neutral glycosphingolipids GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AB00
  • CPS
  • GalNAcb1-4(Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer
Neutral glycosphingolipids Simple Glc series LMSP05010104
  • Catacerebroside A
  • N-(2R-hydroxy-17Z-tetracosenoyl)-1-beta-glucosyl-9-methyl-sphing-4E,8E-dienine
10930878 837.669384 C49H91NO9
Neutral glycosphingolipids Simple Glc series LMSP05010105
  • Catacerebroside B
  • N-(2R-hydroxy-17Z-tetracosenoyl)-1-beta-glucosyl-4R-hydroxy-sphinganine
10909053 843.679949 C48H93NO10
Neutral glycosphingolipids Simple Glc series LMSP05010106
  • Catacerebroside C
  • N-(2,3-dihydroxy-17Z-tetracosenoyl)-1-beta-glucosyl-4R-hydroxy-sphinganine
11768080 859.674864 C48H93NO11
Neutral glycosphingolipids Simple Glc series LMSP05010132
  • Cerebroside A
  • N-(2-hydroxy-3E-hexadecenoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine
171119588 725.544184 C41H75NO9

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024